People · Operator
Named in public records as an officer, director or promoter · active 2012–2026 · Other Technology, Healthtech, Software / Tech, Pharma, Media & Content
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellular Longevity, Inc. | — | Other Technology | Series C | $137.3M | $190.5M | 2024 |
| Health Data Vision, Inc. | — | Healthtech | Series B | $66.7M | $153.8M | 2021 |
| Relay Financial Technologies Inc. | — | Software / Tech | Series B | $43.3M | $205.5M | 2024 |
| Appconomy, Inc. | — | Other Technology | Series A | $28.6M | $29.5M | 2012 |
| Gamma Labs, Inc. | — | Software / Tech | Series B | $25.9M | $382.9M | 2022 |
| Switch Therapeutics Inc. | — | Pharma | Series B | $23.3M | $326.7M | 2022 |
| Daytona Platforms Inc. | — | Software / Tech | Series B | $23.3M | $100.5M | 2026 |
| Bad Panda, Inc. | — | Other Technology | Series A | $10.5M | $166.4M | 2018 |
| Strimmerz Media, Inc. | — | Media & Content | Series A | $9.2M | $73.3M | 2022 |
| Agora Health Inc. | — | Healthtech | Series A | $4.6M | $49.8M | 2022 |
| Stray Bombay Co | — | Other Technology | Seed | $2.0M | $47.5M | 2021 |
Kevin Zhang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Zhang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Williams | 1 | 17 |
| Andrew Adams | 1 | 13 |
| Dylan Morris | 1 | 8 |
| Yves Sisteron | 1 | 8 |
| Matt Turck | 1 | 8 |
| Michael Evans | 1 | 5 |
| Steve Papermaster | 1 | 3 |
| Yvette Bright | 1 | 3 |
| Todd Peterson | 1 | 3 |
| Brian Magierski | 1 | 3 |
| Victor Chaltiel | 1 | 3 |
| Steven G. Papermaster | 1 | 2 |
| Bruno Jactel | 1 | 2 |
| Linda Rhodes | 1 | 2 |
| Mark Eastwood | 1 | 2 |
| Hugh Roome | 1 | 2 |
| Blake Scholl | 1 | 2 |
| Scott Law | 1 | 2 |
| James Jerlecki | 1 | 2 |
| Scott Lahman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.